|Articles|February 1, 2001
- Pharmaceutical Executive-02-01-2001
- Volume 0
- Issue 0
A Right to Dream
Author(s)Wayne Koberstein
Managing expectations is the new alchemy. All manipulators of opinion, from the US president down to the humblest peddler, now seek to minimize what people expect
Advertisement
Articles in this issue
over 25 years ago
The Top Ten Marketing Challenges in Neurologyover 25 years ago
Woman With a Mission: Pfizer's Lisa Egbuonu-DavisAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
The Significance of FDA’s First Warning Letter for Inappropriate Use of AI
2
Jazz Pharmaceuticals to Acquire Actio Biosciences for $1.32 Billion
3
Generating Commercial Evidence from Agentic Field and Brand Engagement to Accelerate Launch Performance
4
M&A Roundup: Novo Nordisk Enters AI Drug Discovery Partnership with Amazon, Innate Pharma Partners with Sobi, Innovent Enters Commercialization Agreement with Daiichi Sankyo
5